BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1401831)

  • 1. Testosterone and androgen metabolism in pancreatic cancer.
    Sperti C; Bonadimani B; Militello C; Cappellazzo F; Pedrazzoli S; Guolo P
    J Clin Gastroenterol; 1992 Sep; 15(2):161-2. PubMed ID: 1401831
    [No Abstract]   [Full Text] [Related]  

  • 2. Androgen profile in patients with pancreatic carcinoma.
    Sperti C; Bonadimani B; Guolo P; Militello C; Cappellazzo F; Pasquali C; Pedrazzoli S
    Ital J Gastroenterol; 1992; 24(6):328-31. PubMed ID: 1515658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low levels of testosterone in patients with pancreatic carcinoma].
    Militello C; Sperti C; Marra S; Pasquali C; Bonadimani B; Cappellazzo F; Petrin P; Scandellari C; Pedrazzoli S
    Minerva Chir; 1988 Apr; 43(7):581-6. PubMed ID: 3140070
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancreatic cancer and androgen metabolism: high androstenedione and low testosterone serum levels.
    Fernández-del Castillo C; Robles-Díaz G; Díaz-Sánchez V; Altamirano A
    Pancreas; 1990 Sep; 5(5):515-8. PubMed ID: 2235963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low serum testosterone/dihydrotestosterone ratio in patients with pancreatic carcinoma.
    Robles-Diaz G; Diaz-Sanchez V; Mendez JP; Altamirano A; Wolpert E
    Pancreas; 1987; 2(6):684-7. PubMed ID: 3438305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Testosterone-dihydrotestosterone ratio in the differential diagnosis of pancreatic disease].
    Sándor Z; Tulassay Z; Bodrogi L; Papp J; Szathmári M; Fehér T
    Orv Hetil; 1989 Jun; 130(26):1387-8. PubMed ID: 2748159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum testosterone:dihydrotestosterone ratio and CA 19-9 in the diagnosis of pancreatic cancer.
    Robles-Díaz G; Díaz-Sánchez V; Fernández-del Castillo C; Morales M; Aceves G; Galván E; Altamirano A
    Am J Gastroenterol; 1991 May; 86(5):591-4. PubMed ID: 2028950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C reactive protein in pancreatic cancer and chronic pancreatitis.
    Basso D; Fabris C; Meani A; Del Favero G; Vianello D; Angonese C; Meggiato T; Bellinvia S; Fogar P; Petrin P
    Ann Clin Res; 1988; 20(6):414-6. PubMed ID: 3218913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess.
    Wiebe RH; Morris CV
    Obstet Gynecol; 1983 Mar; 61(3):279-84. PubMed ID: 6296743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble interleukin-2 receptor in pancreatic cancer and chronic pancreatitis.
    Pezzilli R; Billi P; Beltrandi E; Mancini R; Casadei-Maldini M; Casadei R; Greco VM; Campione O; Miglioli M
    Ital J Gastroenterol; 1994 Apr; 26(3):137-40. PubMed ID: 8061340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An endocrine marker for pancreatic cancer.
    Tulassay Z; Sándor Z; Bodrogi L; Papp J; Fehér T
    BMJ; 1988 Dec; 297(6661):1447-8. PubMed ID: 3147010
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic carcinoma and low serum testosterone; a correlation secondary to cancer cachexia?
    Todd BD
    Eur J Surg Oncol; 1988 Jun; 14(3):199-202. PubMed ID: 3371470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal involvement in chronic pancreatic disease: effects on trypsin and amylase plasma-urine transfer.
    Fabris C; Basso D; Del Favero G; Benini L; Angonese C; Piccoli A; Plebani M; Burlina A; Naccarato R
    Int J Pancreatol; 1988; 3 Suppl 1():S59-65. PubMed ID: 2463319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma androgen, (testosterone and androstenedione) levels in postmenopausal women].
    Sorcini G; Sciarra F; Concolino G; Piro C
    Folia Endocrinol; 1974 Dec; 27(6pt2):696-705. PubMed ID: 4480666
    [No Abstract]   [Full Text] [Related]  

  • 15. [Androgen status in rabbits after long-term administration of non-steroid androgen antagonist niftolid].
    Varga SV; Sinitsyn PV; Tarasenko LV
    Fiziol Zh (1978); 1990; 36(3):52-5. PubMed ID: 2394250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limits of CEA and ferritin in the diagnosis of pancreatic cancer.
    Plebani M; Fabris C; Basso D; Del Favero G; Angonese C; Leandro G; Di Mario F; Burlina A; Naccarato R
    Int J Pancreatol; 1988; 3 Suppl 1():S113-7. PubMed ID: 3209864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prostate-specific antigen in pancreatic disease.
    Pezzilli R; Bertaccini A; Billi P; Zanarini L; Miglio F; Martorana G
    Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):580-3. PubMed ID: 10604096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The levels of androgen in serum in female acne patients.
    Schmidt JB; Spona J
    Endocrinol Exp; 1985 Mar; 19(1):17-23. PubMed ID: 3157562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera.
    Zhao J; Patwa TH; Qiu W; Shedden K; Hinderer R; Misek DE; Anderson MA; Simeone DM; Lubman DM
    J Proteome Res; 2007 May; 6(5):1864-74. PubMed ID: 17428079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Androgen metabolism in uraemic men.
    van Kammen E; Thijssen JH; Schwarz F
    J Endocrinol; 1975 Mar; 64(3):49P. PubMed ID: 1133537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.